Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis
出版年份 2012 全文链接
标题
Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis
作者
关键词
-
出版物
HEPATOLOGY
Volume 56, Issue 2, Pages 622-631
出版商
Wiley
发表日期
2012-02-28
DOI
10.1002/hep.25679
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Coordinated Regulation of Polycomb Group Complexes through microRNAs in Cancer
- (2011) Qi Cao et al. CANCER CELL
- Gene silencing by microRNAs: contributions of translational repression and mRNA decay
- (2011) Eric Huntzinger et al. NATURE REVIEWS GENETICS
- The MicroRNA miR-139 Suppresses Metastasis and Progression of Hepatocellular Carcinoma by Down-regulating Rho-Kinase 2
- (2010) Carmen Chak–Lui Wong et al. GASTROENTEROLOGY
- MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2
- (2010) Linhui Liang et al. HEPATOLOGY
- Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells
- (2010) Dimitrios Iliopoulos et al. MOLECULAR CELL
- An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB
- (2010) Junxia Min et al. NATURE MEDICINE
- Roles of small RNAs in tumor formation
- (2010) Gianpiero Di Leva et al. TRENDS IN MOLECULAR MEDICINE
- DIANA-mirPath: Integrating human and mouse microRNAs in pathways
- (2009) G. L. Papadopoulos et al. BIOINFORMATICS
- MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1
- (2009) R. Garzon et al. BLOOD
- MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity
- (2009) H. Su et al. CANCER RESEARCH
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
- (2009) Janaiah Kota et al. CELL
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion
- (2009) Carmen Chak-Lui Wong et al. HEPATOLOGY
- MYC stimulates EZH2 expression by repression of its negative regulator miR-26a
- (2008) S. Sander et al. BLOOD
- Exploration of Tumor-Suppressive MicroRNAs Silenced by DNA Hypermethylation in Oral Cancer
- (2008) K.-i. Kozaki et al. CANCER RESEARCH
- The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma
- (2008) Motoko Sasaki et al. LABORATORY INVESTIGATION
- EZH1 Mediates Methylation on Histone H3 Lysine 27 and Complements EZH2 in Maintaining Stem Cell Identity and Executing Pluripotency
- (2008) Xiaohua Shen et al. MOLECULAR CELL
- The impact of microRNAs on protein output
- (2008) Daehyun Baek et al. NATURE
- Widespread changes in protein synthesis induced by microRNAs
- (2008) Matthias Selbach et al. NATURE
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- Repression of E-cadherin by the polycomb group protein EZH2 in cancer
- (2008) Q Cao et al. ONCOGENE
- Deleted in Liver Cancer 1 (DLC1) Negatively Regulates Rho/ROCK/MLC Pathway in Hepatocellular Carcinoma
- (2008) Carmen Chak-Lui Wong et al. PLoS One
- A microRNA DNA methylation signature for human cancer metastasis
- (2008) A. Lujambio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
- (2008) S. Varambally et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started